All In Biotech

Drug Trial Radar · NCT00343096

Randomized Trial Comparing 3 Routes of Delivering Lorazepam to Children.

Buccal, Intranasal or Intravenous Lorazepam for the Treatment of Acute Convulsions in Children in Blantyre, Malawi: a Randomized Trial

Last checked: Nov 19, 2026Latest source record: Jul 10, 2012 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedPivotal-lookingPhase 3. Randomized with 800 participants. This is a heuristic, not a regulatory label.

Status

Terminated

Enrollment

800

Actual

Start

Jun 2006

Primary completion

Mar 2009

Study completion Mar 2009

Sponsor

Lead sponsor
Kamuzu University of Health SciencesAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jun 22, 2006

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Factorial
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 2 months, up to 15 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study aims to address the hypothesis that Lorazepam (an anticonvulsant) is as effective when given via the intranasal or buccal route as the intravenous route in terminating convulsions in children.

Conditions

  • Status Epilepticus
  • Convulsions

Interventions

  • LorazepamDrug

    All doses 0.1mg/kg once, repeat after 10 minutes x1

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Whether cessation of fit was achieved within ten minutes or not.

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Queen Elizabeth Central Hospital, Paediatric Dept, Box 360

    Blantyre, Malawi

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.